Use of a nonselective endothelin receptor antagonist in idiopathic pulmonary hypertension
Idiopathic (primary) pulmonary hypertension (IPH) is a rare disease of unknown etiology, which is characterized by elevated pulmonary artery pressure, increased total pulmonary vascular resistance, frequently a malignant course with evolving right ventricular decompensation, and a fatal outcome. The...
Main Authors: | Ol'ga Aleksandrovna Arkhipova, Tamila Vital'evna Martynyuk, Valentina Kirillovna Lazutkina, Dil'bar Mukumovna Ataullakhanova, Ol'ga Vladimirovna Stukalova, Nikolay Mikhaylovich Danilov, Lyudmila Evgen'evna Samoylenko, Irina Evgen'evna Chazova, O A Arkhipova, T V Martynyuk, V K Lazutkina, D M Ataullakhanova, O V Stukalova, N M Danilov, L E Samoilenko, I E Chazova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2010-11-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/30759 |
Similar Items
-
Fleita is a Russian randomized, open-label, multicenter, comparative program for the evaluation of the efficacy and safety of the fixed combination drug Tarka (ABBOTT Laboratories, USA) versus optional sustained-release antihypertensive drugs in the treatment of patients with arterial hypertension and cognitive disorders (stepwise strategy)
by: Irina Evgen'evna Chazova, et al.
Published: (2009-12-01) -
Modern scientific journal of the new generation and best academic traditions
by: Goryacheva Ol'ga Evgen'evna
Published: (2014-05-01) -
Endothelin receptor antagonist bosentan role in modern strategy for patients with pulmonary arterial hypertension treatment
by: O A Arkhipova, et al.
Published: (2018-06-01) -
Final results of STRATEGYA Study (Russian Comparative Programme on a fixed,low-dose perindopril/indapamide combination efficacy in hypertensive patients with inadequateblood pressure control): use of a fixed, low- dose perindopril/indapamide combination in hypertensivepatients in real clinical practice
by: Tamila Vital'evna Martynyuk, et al.
Published: (2009-03-01) -
Bosentan use in pulmonary arterial hypertension: Russian and foreign experience
by: Z S Valieva, et al.
Published: (2017-08-01)